No Q3 earnings call will be held as InMode's special committee reviews a strategic proposal.
InMode Ltd. reported preliminary Q3 2026 revenue of $91.8M-$92.0M and reaffirmed full-year guidance of $365M-$375M. The company will not hold an earnings call due to a strategic proposal review by its special committee. Final results will be released on November 11, 2026, and may differ from preliminary figures.
How this was made
The 30-second read
Why it matters
The lack of a call limits immediate market commentary, likely keeping the stock flat or slightly down.
Market read
Low‑impact corporate update; no new earnings numbers or material events.
What to watch
Potential upcoming strategic proposal may drive future upside if disclosed.
Background
InMode provides RF‑based medical devices. The company is finalizing Q3 results and chose not to host an investor call while a special committee reviews a strategic proposal.
Ticker impact
InMode announced it will not hold a Q3 earnings call and released preliminary Q3 revenue guidance of $91.8M‑$92.0M.
likely modest pressure as the market prices in the lack of a call and limited guidance
No new financial data beyond previously released guidance; only the call cancellation is new, which typically dampens short‑term sentiment.
Market effects
Minimal impact on the med‑tech sector; peers unchanged.
No regional effect; company is US‑listed.
Low relevance globally.
Counterpoint
Investors could view the call cancellation as a chance to buy on reduced short‑term volatility.
Key entities
- CompanyInMode Ltd.
Medical technology firm issuing the statement.
